About
Cell & Peptide-Based Therapies
Areas of Focus
Categories
Gene Therapy, RNA & Peptide TherapyStem Cell & Cellular TherapyBoston & New England
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
52
By Phase
PHASE1: 2
By Status
TERMINATED: 3
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
2022
2023
Today
Hover over trial bars to see details
Recent Trials
NCT04762225Lead Sponsor
RPTR-168 in Patients With Human Papillomavirus Strain 16 (HPV-16) E6/E7 Positive Tumors and Melanoma
PHASE1Terminated
7 participants
Started: May 10, 2021 · Completed: Oct 11, 2022
NCT05061940Lead Sponsor
This SCR-103 Protocol Will Permit Sites to Proactively Assess TAA, HLA and HPV-16 Status in Patients With Selected Solid Tumors to Determine Suitability for Repertoire Immune Medicines Treatment Protocols.
N/ATerminated
22 participants
Started: May 5, 2021 · Completed: Oct 11, 2022
NCT03815682Lead Sponsor
RPTR-147 in Patients With Selected Solid Tumors and Lymphomas
PHASE1Terminated
23 participants
Started: Oct 24, 2018 · Completed: Oct 11, 2022
Locations (1)
Headquarters
Cambridge, MA, United States
Map
Loading map...